McKenna's Pharmacology for Nursing, 2e

978

Index

Children continued gastrointestinal secretions, drugs affecting, 899 hypoglycaemic agents, 574 hypothalamic and pituitary agents, 523 immune modulators, 260 laxatives and antidiarrhoeal agents, 917 lipid-lowering agents, 736 lower respiratory tract agents, 866 male reproductive system, drugs affecting, 629 muscle relaxants, 386 neuromuscular junction (NMJ) blocking agents, 435 opioids, 401 psychotherapeutic agents, 335 suicide, 328 thyroid and parathyroid agents, 554 upper respiratory tract agents, 844 urinary tract agents, 820 vaccines, 274, 275–277 parent education, 284–285 Chinese angelica, 963 Chloral hydrate, 313 Chlorambucil, 190, 195, 196, 198 Chloramphenicol, 87, 957 Chlorhexidine gluconate, 950 Chloride regulation, 798 Chloroquine, 166–169, 172 Chlorpheniramine, 852, 854 Chlorpromazine, 334–337, 341, 931, 932 Chlorpropamide, 587 Chlorthalidone, 675, 805, 807 Cholera, 281 Cholesterol, 729, 732–733 absorption inhibitors, 729, 738, 743–745 adverse effects, 744 care considerations, 744–745 contraindications and cautions, 743 drug–drug interactions, 744 pharmacokinetics, 743 therapeutic actions and indications, 743 combination therapy, 740, 746 Cholestyramine, 729, 735, 737, 739 Cholinergic agonists, 487–499 adults, 489 children, 489 direct-acting, 487, 488–491 adverse effects, 490 care considerations, 490–491 contradictions and cautions, 490 drug–drug interactions, 490 pharmacokinetics, 490 therapeutic actions and indications, 489–490 indirect-acting, 487, 491–498 adverse effects, 495 Alzheimer’s disease, agents for, 492–496 care considerations, 496 contraindications and cautions, 495 critical thinking scenario, 497–498 drug–drug interactions, 495

myasthenia gravis, agents for, 492 pharmacokinetics, 494–495 therapeutic actions and indications, 493–494 miosis, 487, 490 older adults, 489 Cholinergic crisis versus myasthenic crisis, 493 Cholinergic receptors, 444, 451, 452 Cholinergic response, 450–452 Cholinesterase inhibitors, 437 Chondroitin, 963 Chong cao fungi, 964 Choriogonadotropin alpha, 526, 530, 617, 618 Chorionic gonadotropin, 526, 530, 617, 618 Chronic conditions, 44 Chronic obstructive pulmonary disease (COPD), 834, 839, 865 Ciclopirox, 157, 951 Cidofovir, 132, 133 Cilia, 834, 835 Cilostazol, 755, 758 Cimetidine, 896, 897–899, 901, 903 Cinacalcet hydrochloride, 564 Cinchocaine, 425, 426 Cinchonism, 163 Ciprofloxacin, 90, 106, 107, 118, 820, 957 Ciprofloxacin/hydrocortisone, 951 hypertension, 652 hypotension, 652 pulmonary, 649–650 renin–angiotensin–aldosterone system, 652, 653 systemic, 649, 650 systemic arterial pressure, 652 vasomotor tone, 652 venous pressure, 652–653 Cisatracurium, 434, 435, 437 Cisplatin, 195–197 Chrysotherapy, 240, 252 Chylomicron, 729, 731 Chyme, 888, 891 Ciclesonide, 875, 877, 953 Circle of Willis, 298 Circulation, 649–653 coronary circulation, 650–652 heart failure, 652–653

Clotting, 751–754 anticlotting, 754 clot resolution, 754

factors, 750, 751 studies, 760, 763 vitamin K and, 763 Clozapine, 334, 336, 338, 341 Coagulation, drugs affecting, 750–771 adults, 752 blood coagulation, 751–754 children, 752 clotting. See Clotting disorders affecting blood coagulation, 754–755 haemorrhagic disorders, 755 thromboembolic disorders, 754–755 drugs affecting clot formation and resolution, 755–767 anticoagulant adjunctive therapy, 766 anticoagulants. See Anticoagulants antiplatelet agents. See Antiplatelet agents low-molecular-weight heparins, 751, 757, 766 thrombolytic agents. See Thrombolytic agents drugs used to control bleeding, 767–771 antihaemophilic agents. See Antihaemophilic agents haemostatic agents. See Haemostatic agents older adults, 752 Coagulation factors, 767–769 Cocaine, 67 Codeine, 401, 402, 844, 845 Colaspase, 200, 201, 203 Colestipol, 735, 737 Coleus forskohlii , 964 Combination therapy, 86, 93 Co-methylcobalamin, 787 Comfrey, 964 Common cold, 834, 837–838 Competitive antagonists, 15, 17 Complement proteins, 228, 234 Complementary therapies. See Alternative and complementary therapies Conductivity, 642, 645, 697 Constipation, 916, 917 opioid-induced, 405 Consumer awareness, 61–62 Internet, 61–62 media influence, 61 Contraceptives, 611–612, 616–617 Contraindications, reviewing, 32 Convulsions, 352, 353 COPD (chronic obstructive pulmonary disease), 834, 839 Coreceptor antagonist, 126 Coriander, 471, 582, 964 Coronary artery disease (CAD), 713, 714–715, 730–731 acute myocardial infarction, 715 angina, 715 risk factors, 729–732 treatment, 731 Coronary circulation, 650–652

Citalopram, 325, 326 Cladribine, 193, 200 Clarithromycin, 103, 122 Clary, 613

Clindamycin, 91, 104, 122, 123, 953 Clinical decision making, 42, 43–46 Clobetasol butyrate, 953

Clodronate, 566, 567 Clofaimine, 118, 119 Clofarabine, 200, 201

Clomiphene, 606, 617–619 Clomipramine, 317, 318, 319 Clonazepam, 354, 357, 359–360 Clonidine, 462, 463, 676 Clopidogrel, 755, 758 Clotrimazole, 157, 158, 951